Literature DB >> 31745489

Successful Management of Anti-mGluR1 Encephalitis with Immunosuppressive Treatment: Dengue Virus as a Trigger?

Hugo Chaumont1,2,3, Aimée Petit4,5,6, Tanicia Mameri1,2, Romain Schollhammer2,7, Jérome Honnorat8,9, Annie Lannuzel1,2,3.   

Abstract

Entities:  

Keywords:  Dengue virus; anti; autoimmune encephalitis; cerebellitis; immunosuppressive therapy

Year:  2019        PMID： 31745489      PMCID： PMC6856456          DOI： 10.1002/mdc3.12841

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN： 2330-1619


× No keyword cloud information.
  3 in total

1.  Metabotropic glutamate receptor type 1 autoantibody-associated cerebellitis: a primary autoimmune disease?

Authors:  Romain Marignier; Florian Chenevier; Veronique Rogemond; Peter Sillevis Smitt; Christel Renoux; Gaëlle Cavillon; Geraldine Androdias; Sandra Vukusic; Francesc Graus; Jérôme Honnorat; Christian Confavreux
Journal:  Arch Neurol       Date:  2010-05

2.  Reversible myoclonus-ataxia encephalitis related to anti-mGLUR1 autoantibodies.

Authors:  Cedric Gollion; Julia Dupouy; Meryl Roberts; Marion Simonetta-Moreau; Christine Brefel Courbon; Olivier Rascol; Jerome Honnorat; Fabienne Ory Magne
Journal:  Mov Disord       Date:  2019-02-13       Impact factor: 10.338

3.  Metabotropic glutamate receptor type 1 autoimmunity: Clinical features and treatment outcomes.

Authors:  A Sebastian Lopez-Chiriboga; Lars Komorowski; Tania Kümpfel; Christian Probst; Shannon R Hinson; Sean J Pittock; Andrew McKeon
Journal:  Neurology       Date:  2016-02-17       Impact factor: 9.910
  3 in total
  1 in total

Review 1.  Autoimmune Encephalitis in Latin America: A Critical Review.

Authors:  Gabriel de Albuquerque Vasconcelos; Rodrigo Montenegro Barreira; Karmelita Emanuelle Nogueira Torres Antoniollo; Alina Maria Nuñez Pinheiro; Cíntia Fernandes Rodrigues Maia; Danyela Martins Bezerra Soares Alves; Paulo Ribeiro Nóbrega; Pedro Braga-Neto
Journal:  Front Neurol       Date:  2021-01-21       Impact factor: 4.003
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.